ewsba.se
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is one of the top cheap stocks to buy with the biggest upside potential. BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced on May 2 new research from studies of VOXZOGO® in children with achondroplasia exhibiting positive impacts on important health indicators, including arm span and bone density. The company will present the data, along with new data from studies of VOXZOGO in hypochondroplasia, at the Pediatric Endocrine Society’s 2026 Annual Meeting (PES) in San Francisco.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) further reported that data from the three ongoing long-term extension clinical trials showed the effects of long-term treatment with VOXZOGO on measures beyond height, including bone health and arm span. According to researchers, arm span Z-scores improved from baseline in all age groups, and the arm span-to-height ratio also remained stable over time, highlighting that treatment resulted in proportional skeletal growth.
In addition, management reported that children who initiated treatment with VOXZOGO after age 5 also attained a mean difference in standing height of 10.60 cm after six years of treatment and 13.59 cm after eight years of treatment, compared with untreated natural history cohorts.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) develops and commercializes therapies for serious and life-threatening medical conditions and rare diseases. The company’s product pipeline includes Valoctocogene roxaparvovec, Vosoritide, and BMN 307.
While we acknowledge the potential of BMRN as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 15 Stocks That Will Make You Rich in 10 Years AND 12 Best Stocks That Will Always Grow.
Disclosure: None. Follow Insider Monkey on Google News.